GSAC logo

GelStat Corp. Stock Price

OTCPK:GSAC Community·US$1.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

GSAC Share Price Performance

US$0.0003
0.00 (0.00%)
US$0.0003
0.00 (0.00%)
Price US$0.0003

GSAC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with imperfect balance sheet.

4 Risks
1 Reward

GelStat Corp. Key Details

US$363.5k

Revenue

US$107.6k

Cost of Revenue

US$256.0k

Gross Profit

US$539.4k

Other Expenses

-US$283.4k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.000076
70.41%
-77.96%
-70.7%
View Full Analysis

About GSAC

Founded
2002
Employees
2
CEO
Javier Acosta
WebsiteView website
www.gelstat.com

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialty distributors, and catalog merchandisers both directly and through external sales brokers. GelStat Corporation was founded in 2002 and is headquartered in Palm City, Florida.

Recent GSAC News & Updates

No updates

Recent updates

No updates